Directed new share issue in Oncopeptides AB (SE) — SEK 314 million

Carnegie acted as joint bookrunner in the directed new share issue of 3,980,000 shares priced at SEK 79 per share. Oncopeptides is a research and development stage pharmaceutical company developing drugs for the treatment of cancer. March 2018.